Direct Nucleic Acid Amplification Without Extraction for Pathogen Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting viral and bacterial pathogens, such as RT-PCR, are time-consuming and expensive, requiring complex steps like nucleic acid extraction and purification, which hinder rapid diagnosis.

Innovation Solution

A reagent mixture that allows for direct amplification of nucleic acids from biological samples without prior extraction, using DNA polymerase, buffer, and optional reverse transcriptase, with components like KCl, surfactants, and heat to enhance lysis and inhibit amplification inhibitors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If RT-PCR or standard PCR methods are used for pathogen detection, then sensitivity and specificity are improved, but the complexity of the procedure and time required increase due to nucleic acid extraction and purification steps

Engineering Contradiction:
Improvedetection sensitivityVSAvoidprocedure complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines the nucleic acid extraction, purification, and amplification steps into a single integrated reaction system. The buffer composition includes components that simultaneously perform cell lysis, nucleic acid purification, and PCR amplification, eliminating the need for separate extraction and purification steps while maintaining detection sensitivity.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The buffer system is designed to perform multiple functions: it acts as a lysis buffer to break down cells and release nucleic acids, a purification buffer to remove inhibitors and isolate nucleic acids, and a PCR buffer to support amplification. This multi-functional buffer replaces multiple separate reagents and steps.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If nucleic acid extraction and purification steps are performed, then amplification quality is improved, but the time required for diagnosis increases

Engineering Contradiction:
Improveamplification qualityVSAvoiddiagnosis time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The buffer contains pre-formulated components that perform extraction and purification actions during the initial stages of the reaction, before amplification begins. The lysis and purification processes are initiated simultaneously with the amplification setup, eliminating sequential waiting time.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The reaction proceeds continuously without interruption or intermediate steps. The lysis, purification, and amplification processes overlap in time, with the buffer maintaining optimal conditions for each process simultaneously, eliminating idle time between steps.

Inventive Principle:
Principle #20Continuity of useful action

3Measurement precision

If traditional PCR methods are used, then detection accuracy is improved, but the cost and technical requirements increase

Engineering Contradiction:
Improvedetection accuracyVSAvoidtechnical requirements
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent uses a disposable, pre-formulated buffer system that can be directly added to samples without requiring complex equipment or specialized technical skills for preparation. The buffer is designed as a ready-to-use reagent that simplifies the workflow and reduces technical barriers.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The buffer acts as an intermediary that mediates between the crude sample and the amplification reaction. It contains components that neutralize inhibitors, protect nucleic acids, and create optimal reaction conditions, bridging the gap between simple sample collection and accurate detection.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid and sensitive detection of pathogens like influenza and C. difficile with equivalent or improved sensitivity compared to traditional methods, reducing the need for nucleic acid extraction and purification steps.

Implementation Method 1

contacting the sample with a DNA polymerase and a buffer under conditions suitable for amplification of the target nucleic acid from the sample

Methodology Applied
Scientific EffectPolymerase chain reaction:

Implementation Method 2

The dsDNA is then denaturized at about 95°C, so that the two strands separate

Methodology Applied
Scientific EffectThermal denaturation: Heating

Implementation Method 3

an RNA strand is first reverse transcribed into its DNA complement (cDNA) using the enzyme reverse transcriptase

Methodology Applied
Scientific EffectReverse transcription: Enzyme

Data Source

PatentEP4715060A2Direct amplification and detection of viral and bacterial pathogens
Publication Date: 2026.03.25 QUEST DIAGNOSTICS INVESTMENTS INC
  • EP4715060A2 patent drawingFigure 1A
  • EP4715060A2 patent drawingFigure 1B
  • EP4715060A2 patent drawingFigure 2A

AI summary

Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.